Wockhardt, Orchid get US nod for terbinafine HCL

MUMBAI, July 4 (Reuters) - Wockhardt Ltd. (WCKH.BO) and Orchid Chemicals & Pharmaceuticals Ltd. (ORCD.BO) have got U.S. Food and Drug Administration (FDA) approval for their terbinafine hydrochloride tablets, the FDA Web site showed on Wednesday.

Terbinafine is the generic equivalent of Novartis' (NOVN.VX) anti-fungal brand Lamisil.

((Reporting by Bharghavi Nagaraju; editing by Sunil Nair; Reuters Messaging: bharghavi.nagaraju.reuters.com@reuters.net; +91 22 6636 9059)) Keywords: WOCKHARDT TERBINAFINE/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM100189